Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Business
Derek Rose

Aussie cancer diagnosis firm expands with $3.3b merger

ASX-listed Telix Pharmaceuticals is set to acquire German company ITM Isotope Technologies Munich. (David Crosling/AAP PHOTOS)

An Australian company that manufactures radioactive drugs that help treat and diagnose diseases will acquire a German isotope maker in a transaction worth up to $3.3 billion.

ASX-listed Telix Pharmaceuticals will pay at least $US1.65 billion ($2.3 billion) in scrip upfront for ITM Isotope Technologies Munich, a private radioisotope manufacturer with a global distribution network that spans more than 65 countries.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.